AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Zymeworks Inc. Completes Acquisition of Theravance Biopharma, Inc.
Acquiring Company
ZYMEWORKS
Acquired Company
Theravance Biopharma
Vancouver
DublinBiotechnologyBiotechnologyHealth CareDescription
On September 23, 2026, Zymeworks Inc. completed the acquisition of Theravance Biopharma, Inc. through a merger agreement. This strategic move is expected to enhance Zymeworks' portfolio in the biotechnology sector. The merger was finalized as planned, paving the way for future innovations and developments.
Fundz sees it the moment ZYMEWORKS makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Theravance Biopharma?
Theravance Biopharma was acquired by ZYMEWORKS, based in Vancouver. The deal was reported on September 23, 2026. Zymeworks Inc. (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. ZYMEWORKS is publicly traded (ZYME) and operates in Biotechnology.
When did ZYMEWORKS acquire Theravance Biopharma?
ZYMEWORKS's acquisition of Theravance Biopharma was reported on September 23, 2026. On September 23, 2026, Zymeworks Inc. completed the acquisition of Theravance Biopharma, Inc. through a merger agreement. This strategic move is expected to enhance Zymeworks' portfolio in the biotechnology sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Theravance Biopharma do?
Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference® in people's lives. It is publicly traded (TBPH), operating in Biotechnology, and is based in Dublin.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.